Electric field device shows promise for tough brain tumors
Disease control
Completed
This study tested a wearable device called NOVOTTF-200A in adults with recurrent Grade III anaplastic astrocytoma, a type of brain cancer. The goal was to see if the device could stop tumor growth for at least six months. Only one person enrolled, and the study looked at safety a…
Phase: NA • Sponsor: Daniela A. Bota • Aim: Disease control
Last updated May 26, 2026 12:08 UTC